114 related articles for article (PubMed ID: 37620536)
1. ASO Author Reflections: Closing the Gap: A Call to Action to Improve Access and Outcomes of Peritoneal Surface Malignancy Care.
Winicki NM; Johnston FM; Greer JB
Ann Surg Oncol; 2023 Nov; 30(12):7863-7864. PubMed ID: 37620536
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: Survivorship in the Balance: The Paradox of Longevity and Quality of Life in Patients with Peritoneal Surface Malignancy.
Allen CJ
Ann Surg Oncol; 2023 Nov; 30(12):7862. PubMed ID: 37626251
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Prognosticating the Treatment Outcome for Primary Peritoneal Surface Malignancy: Time for an Overhaul of Scoring Systems?
Ihemelandu C
Ann Surg Oncol; 2023 Mar; 30(3):1838-1839. PubMed ID: 36629992
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Repeated Intraperitoneal Paclitaxel with Systemic Chemotherapy as the First-Line Treatment for Peritoneal Malignancy.
Kitayama J; Saito S; Yamaguchi H; Lefor AK; Ishigami H; Sata N
Ann Surg Oncol; 2021 Jul; 28(7):3871-3872. PubMed ID: 33432487
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: How to Detect Peritoneal Metastases of Urachal Carcinoma? The Value of Diagnostic Laparoscopy and Abdominal Cytology in Staging This Rare Malignancy.
Stokkel LE; Mertens LS; van Rhijn BWG
Ann Surg Oncol; 2020 Jul; 27(7):2476-2477. PubMed ID: 32323088
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Distilling Wisdom From Two Decades of Cutaneous Malignant Melanoma at a Peruvian Cancer Institute: A Stirring Call for Action.
Ziegler-Rodriguez G; Ziegler-Rodriguez O; De La Cruz-Ku G; Cotrina-Concha JM; Dunstan J; Pinillos-Portella M; Vilchez-Santillan S; Möller MG
Ann Surg Oncol; 2024 Jul; ():. PubMed ID: 38955994
[No Abstract] [Full Text] [Related]
7. ASO Author Reflections: Predicting Hyperthermia and Its Effect in Patients with Peritoneal Surface Malignancies.
Guerra-Londono CE; Owusu-Agyemang P; Corrales G; Rofaeil MM; Feng L; Fournier K; Cata JP
Ann Surg Oncol; 2022 Mar; 29(3):2100-2101. PubMed ID: 34713370
[No Abstract] [Full Text] [Related]
8. ASO Author Reflections: Disparities in Access to Cytoreductive Surgery.
Goldberg EM; Eng OS
Ann Surg Oncol; 2021 Nov; 28(12):7807-7808. PubMed ID: 34013481
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: The Management of Appendiceal Primary Peritoneal Surface Malignancies.
Russo A; Gangi A
Ann Surg Oncol; 2022 Dec; 29(Suppl 3):589-590. PubMed ID: 35061124
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Racial Disparities in Time to Breast Cancer Treatment-A Call to Action.
Bayard S; Bea VJ
Ann Surg Oncol; 2022 Dec; 29(Suppl 3):599. PubMed ID: 35902498
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: Gastric Cancer with Synchronous Peritoneal Disease-A Clinically Meaningful Survival After CRS and HIPEC in Selected Patients from Italian Peritoneal Surface Malignancies Oncoteam Network.
Marano L; Marrelli D; Roviello F
Ann Surg Oncol; 2021 Dec; 28(13):9071-9072. PubMed ID: 34018086
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Improving Outcomes in Diffuse Malignant Peritoneal Mesothelioma: Challenges and Opportunities.
Leinwand JC; Kluger MD
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):742-743. PubMed ID: 32239340
[No Abstract] [Full Text] [Related]
13. ASO Author Reflections: Tailoring the Extent of Peritoneal Resection for Peritoneal Metastases According to the Primary Tumor Site.
Bhatt A; Glehen O
Ann Surg Oncol; 2020 May; 27(5):1471-1472. PubMed ID: 32162077
[No Abstract] [Full Text] [Related]
14. ASO Author Reflections: Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights from a Multi-center Study.
Yaşar S
Ann Surg Oncol; 2024 Jun; ():. PubMed ID: 38918325
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Long-Term Outcomes After R0 Resection of Colorectal Peritoneal Metastasis.
Shida D
Ann Surg Oncol; 2018 Dec; 25(Suppl 3):832-833. PubMed ID: 30251024
[No Abstract] [Full Text] [Related]
16. ASO Author Reflections: Combination Intra-Peritoneal and Systemic Chemotherapy for Gastric Cancer with Peritoneal Metastases.
Chia DKA; Ang JJ; Sundar R; Kim G; Shabbir A; So JBY; Yong WP
Ann Surg Oncol; 2022 Dec; 29(13):8606-8607. PubMed ID: 36192514
[No Abstract] [Full Text] [Related]
17. ASO Author Reflections: Delays in Breast Cancer Treatment During the COVID Pandemic-Disparities in Delay and a Call to Action.
Chung SH; Sachs TE
Ann Surg Oncol; 2023 Oct; 30(10):6106-6107. PubMed ID: 37434072
[No Abstract] [Full Text] [Related]
18. ASO Author Reflections: Expert Surgical Evaluation is Critical for Patients with Diffuse Malignant Peritoneal Mesothelioma: Lessons Learned from Assessing Outcomes of 2000 Patients.
Bijelic L; Cannon T
Ann Surg Oncol; 2020 Aug; 27(8):2983-2984. PubMed ID: 32274661
[No Abstract] [Full Text] [Related]
19. ASO Author Reflections: Neoadjuvant Systemic Chemotherapy in Isolated Resectable Colorectal Peritoneal Metastases: Ready for Standard of Care?
Flood MP; Ramsay R; Michael M; Heriot AG
Ann Surg Oncol; 2022 Oct; 29(11):6632-6633. PubMed ID: 35412210
[No Abstract] [Full Text] [Related]
20. ASO Author Reflections: Characterizing the Peritoneal Immune Response to the Surgical and Thermal Trauma of Peritoneal Cytoreduction and HIPEC.
Franko J; Ferrel B; Gorvet M
Ann Surg Oncol; 2020 Dec; 27(13):5014-5015. PubMed ID: 32720041
[No Abstract] [Full Text] [Related]
[Next] [New Search]
